Approval · Notice of Compliance 1425 · 2000
PROPOFOL: Notice of Compliance 1425
Issued January 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1425
- Date
- January 17, 2000
- Company
- Novopharm LimitedMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anesthetic/sedative
- Canadian reference product
- DIPRIVAN (Zeneca Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL | 02241504 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML